Discussion
A test using data from 18 blood biomarkers to track disease activity in multiple sclerosis (MS) was able to distinguish true MS relapses from symptom worsening unrelated to active inflammation with high accuracy in a small real-world study. The findings suggest Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test may…